Imagin Medical Inc.
IME
CNSX
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 46.38% | 93.50% | 91.43% | 79.17% | -53.33% |
| Total Depreciation and Amortization | 338.27% | 290.34% | 173.73% | 58.44% | 12.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -60.66% | -128.47% | -126.15% | -113.09% | 200.61% |
| Change in Net Operating Assets | 29,172.73% | 1,938.67% | 2,819.88% | 358.97% | -102.77% |
| Cash from Operations | 74.02% | 58.34% | 49.84% | 36.25% | -22.57% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9,709.26% | -9,709.26% | -4,804.63% | -10,983.33% | 0.00% |
| Cash from Investing | -9,709.26% | -9,709.26% | -4,804.63% | -10,983.33% | 0.00% |
| Total Debt Issued | -60.07% | -67.17% | -40.11% | -34.95% | -11.40% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00% | 0.00% | 0.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -51.31% | -60.13% | -33.01% | -27.21% | -11.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 91.89% | -200.00% | -200.00% | -- |
| Net Change in Cash | 79.47% | -323.56% | 79.87% | -196.47% | -225.94% |
